William Blair & Company’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $714K | Buy |
|
|||||
|
2025
Q2 | $660K | Sell |
|
|||||
|
2025
Q1 | $813K | Buy |
|
|||||
|
2024
Q4 | $894K | Sell |
|
|||||
|
2024
Q3 | $2.15M | Buy |
|
|||||
|
2024
Q2 | $2.09M | Sell |
|
|||||
|
2024
Q1 | $1.95M | Buy |
|
|||||
|
2023
Q4 | $1.77M | Buy |
|
|||||
|
2023
Q3 | $1.28M | Sell |
|
|||||
|
2023
Q2 | $1.28M | Sell |
|
|||||
|
2023
Q1 | $1.62M | Sell |
|
|||||
|
2022
Q4 | $1.72M | Buy |
|
|||||
|
2022
Q3 | $860K | Buy |
|
|||||
|
2022
Q2 | $666K | Sell |
|
|||||
|
2022
Q1 | $999K | Buy |
|
|||||
|
2021
Q4 | $764K | Sell |
|
|||||
|
2021
Q3 | $1.04M | Sell |
|
|||||
|
2021
Q2 | $1.03M | Buy |
|
|||||
|
2021
Q1 | $844K | Buy |
|
|||||
|
2020
Q4 | $604K | Sell |
|
|||||
|
2020
Q3 | $851K | Buy |
|
|||||
|
2020
Q2 | $841K | Buy |
|
|||||
|
2020
Q1 | $591K | Buy |
|
|||||
|
2019
Q4 | $415K | Sell |
|
|||||
|
2019
Q3 | $409K | Sell |
|
|||||
|
2019
Q2 | $519K | Buy |
|
|||||
|
2019
Q1 | $660K | Buy |
|
|||||
|
2018
Q4 | $439K | Buy |
|
|||||
|
2018
Q3 | $467K | Hold |
|
|||||
|
2018
Q2 | $398K | Sell |
|
|||||
|
2018
Q1 | $679K | Sell |
|
|||||
|
2017
Q4 | $745K | Buy |
|
|||||
|
2017
Q3 | $823K | Buy |
|
|||||
|
2017
Q2 | $841K | Buy |
|
|||||
|
2017
Q1 | $612K | Buy |
|
|||||
|
2016
Q4 | $517K | Buy |
|
|||||
|
2016
Q3 | $542K | Buy |
|
|||||
|
2016
Q2 | $409K | Buy |
|
|||||
|
2016
Q1 | $214K | Sell |
|
|||||
|
2015
Q4 | $1.13M | Buy |
|
|||||
|
2015
Q3 | $292K | Sell |
|
|||||
|
2015
Q2 | $345K | Sell |
|
|||||
|
2015
Q1 | $374K | Buy |
|
|||||
|
2014
Q4 | $324K | Buy |
|
|||||
|
2014
Q3 | $252K | Buy |
|
|||||
|
2014
Q2 | – | Sell |
|
|||||
|
2014
Q1 | $373K | Buy |
|